Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
AstraZeneca
McKesson
Baxter
Dow

Last Updated: May 28, 2022

Investigational Drug Information for TRV130


✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for TRV130?

TRV130 is an investigational drug.

There have been 10 clinical trials for TRV130. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2016.

The most common disease conditions in clinical trials are Acute Pain, Fractures, Bone, and [disabled in preview]. The leading clinical trial sponsors are Trevena Inc., Lotus Clinical Research, LLC, and Kestrel Biologic.

There are sixteen US patents protecting this investigational drug and one hundred and eleven international patents.

Recent Clinical Trials for TRV130
TitleSponsorPhase
Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After BunionectomyTrevena Inc.Phase 3
Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After AbdominoplastyTrevena Inc.Phase 3
A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute PainTrevena Inc.Phase 3

See all TRV130 clinical trials

Clinical Trial Summary for TRV130

Top disease conditions for TRV130
Top clinical trial sponsors for TRV130

See all TRV130 clinical trials

US Patents for TRV130

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
TRV130 See Plans and Pricing Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) See Plans and Pricing
TRV130 See Plans and Pricing Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) See Plans and Pricing
TRV130 See Plans and Pricing Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN) See Plans and Pricing
TRV130 See Plans and Pricing Chemically stable compositions of a pharmaceutical active agent in a multi- chambered delivery system for mucosal delivery MUCODEL PHARMA LLC (Greensboro, NC) See Plans and Pricing
TRV130 See Plans and Pricing Methods of treating hyperalgesia TREVENA, INC. (King of Prussia, PA) See Plans and Pricing
TRV130 See Plans and Pricing Opioid receptor ligands and methods of using and making same TREVENA, INC. (King of Prussia, PA) See Plans and Pricing
TRV130 See Plans and Pricing Substituted ureas and methods of making and using same MEBIAS DISCOVERY, INC. (Philadelphia, PA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for TRV130

Drugname Country Document Number Estimated Expiration Related US Patent
TRV130 Australia AU2017261372 2036-05-05 See Plans and Pricing
TRV130 Canada CA3023278 2036-05-05 See Plans and Pricing
TRV130 China CN107847398 2036-05-05 See Plans and Pricing
TRV130 European Patent Office EP3452003 2036-05-05 See Plans and Pricing
TRV130 Hong Kong HK1249728 2036-05-05 See Plans and Pricing
TRV130 Japan JP2019520866 2036-05-05 See Plans and Pricing
TRV130 Japan JP6559912 2036-05-05 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
AstraZeneca
McKesson
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.